The State of Dental Industry Consolidation in 2026: What the Data Actually Shows

Dental consolidation has moved from a talking point at industry conferences to a measurable, structural shift in how American dentistry is owned and operated. But the topic is also thick with inflated market-size projections and loosely sourced "statistics" that don't hold up to scrutiny. This piece separates the two: what the primary data actually says about consolidation, and what it means for practice owners, operators, and the private equity groups backing them.

How Fast Is Consolidation Actually Moving?

The most reliable measure of dental consolidation comes from the American Dental Association's Health Policy Institute (HPI), which surveys practicing dentists directly rather than extrapolating from market models. According to HPI's most recent workforce data, the share of U.S. dentists affiliated with a dental support organization (DSO) reached 16.1% in 2024, more than double the 7.4% recorded in 2015. Private practice ownership has moved in the opposite direction: as of 2023, only 72.5% of U.S. dentists were private practice owners, down from 84.7% in 2005.

The generational split is the more telling number. Among dentists less than 10 years out of dental school, 27% are now DSO-affiliated, up from 24% just a year earlier, compared with only 9% of dentists who graduated more than 25 years ago. Solo practice has become a career-stage phenomenon rather than a default: just 15% of early-career dentists work solo, versus 48% of dentists with 25-plus years of experience. Roughly two in three U.S. dentists now work in a group practice setting of some kind.

Worth flagging for anyone researching this space: some industry blogs cite a figure of 39% DSO affiliation projected for 2026, attributed to LEK Consulting. That number is far outside what HPI's census-style data shows and appears to reflect a different definition of "affiliation" or a forward-looking projection rather than a measured result. When evaluating consolidation statistics, the HPI numbers are the ones with the most transparent, replicable methodology, and they tell a consistent story: steady, compounding growth rather than an industry that has already tipped majority-DSO.

Who's Actually Buying: The Private-Equity-Backed DSO Landscape

Private equity is the primary engine behind DSO growth. Industry trackers estimate roughly 130 PE-backed DSOs currently operate in the U.S., and dental logged more add-on acquisitions in 2024 than any other healthcare vertical — well over 100 deals in a single year. Peer-reviewed research from health economist Kamyar Nasseh puts the share of PE-affiliated dental practices at 1.6% in 2015, rising to 3.0% by 2021 — a smaller absolute number than the broader DSO figures above, but one that roughly doubled in six years and captures a more conservative, academically vetted slice of the same trend.

The largest platforms illustrate the range of ownership structures now competing for the same targets. Heartland Dental, backed by KKR, supports more than 1,900 affiliated practices across 39 states and remains the largest DSO by location count. Aspen Dental is backed by Leonard Green and Ares; MB2 Dental by Charlesbank and Warburg Pincus; Smile Brands by Gryphon Investors. Not every large group follows the PE playbook, though — Pacific Dental Services remains founder-owned, Mortenson Dental Partners operates as an employee stock ownership plan (ESOP), and PepperPointe Partnerships explicitly markets itself as a dentist-owned alternative to private equity consolidation. That distinction matters increasingly to sellers who want scale benefits without ceding long-term clinical or brand control.

Specialty consolidation is running on its own, often faster, track. Oral and maxillofacial surgery has become the highest-multiple segment in dental M&A, typically trading in a 12x–15x EBITDA range, with orthodontics and pediatric dentistry also drawing dedicated roll-up platforms rather than general-dentistry buyers. Pediatric multi-site groups above $2M in EBITDA have traded in a roughly 7.5x–11x band through 2024 and into Q2 2026, with payer mix — fee-for-service versus Medicaid-heavy patient panels — accounting for one to two turns of variance within that range. Group Dentistry Now and Becker's Dental + DSO Review, the two publications most closely tracking deal flow in real time, both describe 2024–2026 as one of the most active stretches in the sector's M&A history.

The mechanics of specialty roll-ups differ somewhat from general-dentistry consolidation. Because oral surgery and orthodontics rely more heavily on referral relationships with general dentists, platforms in these segments often prioritize acquiring practices that anchor a referral network within a metro area, rather than simply maximizing chair count. That referral-network logic is part of why specialty multiples have stayed elevated even as general-dentistry platform multiples compressed during the 2022–2023 rate environment — the strategic value of a well-positioned referral hub doesn't move in lockstep with the cost of acquisition debt the way a standalone general practice's valuation does.

What Practices Are Actually Selling For

Valuation data is where a lot of confusion enters the conversation, mostly because multiples vary enormously by scale and deal type — and both are frequently left out of the headline number. As a baseline, dental practices are trading at adjusted EBITDA multiples that scale sharply with size:

• Sub-$1M EBITDA (solo or small group): roughly 5x–7x, typically structured as tuck-ins to an existing platform
• $1M–$3M EBITDA (regional add-ons): roughly 7x–9x
• $3M–$5M EBITDA (emerging platforms): roughly 9x–11x
• $10M+ EBITDA (platform-scale groups, 10+ locations): roughly 10x–14x, with some Q2 2026 platform transactions reported as high as 15x

Specialty practices generally command a one- to three-turn premium over general dentistry due to higher margins and stickier patient relationships, with oral surgery frequently cited at the top of the range. Deal structure has also normalized: cash typically covers 60–75% of consideration at close, with 10–30% in rollover equity and the remainder in earnouts tied to retained EBITDA over 12–36 months.

It's also worth noting where the market has been. Multiples compressed by roughly one to two turns between the 2021–2022 peak and 2023, tracking the Federal Reserve's rate hikes from near zero to a 5.25–5.50% target by mid-2023 — higher debt costs directly reduced what leveraged DSO buyers could pay. As rates eased through 2024 and into 2026, deal activity and pricing both recovered, though platform-tier multiples remain below their 2021 highs. Below $5M in project cost, SBA 7(a) financing continues to underwrite the majority of solo general-practice acquisitions, meaning the individual-buyer market hasn't disappeared — it has simply become a smaller share of total transaction volume relative to DSO buyers.

Why Consolidation Is Accelerating Now

Four forces are compounding at the same time, which is part of why 2024–2026 has felt like an inflection point rather than a continuation of a slow trend.

Administrative burden and margin compression. Rising costs for clinical supplies, real estate, and labor — combined with a persistent shortage of dental hygienists and assistants — have squeezed independent-practice margins faster than solo owners can absorb through fee increases, especially where PPO reimbursement growth has lagged inflation.

Capital requirements for technology. AI-assisted diagnostics, cloud-based practice management systems, and automated administrative tools increasingly separate competitive practices from the pack, but they require upfront capital that's easier to deploy across a multi-location platform than a single office.

Generational transition. A meaningful share of practice owners are approaching retirement age at the same time that younger dentists are graduating with higher debt loads and less appetite for the operational and regulatory burden of solo ownership — a pairing that pushes both the buy side and the sell side toward DSO structures simultaneously.

Access to capital and buyer competition. With more than 130 PE-backed platforms actively acquiring, and named consolidators publicly reporting five-plus competing offers on well-positioned practices, sellers increasingly have genuine leverage — a dynamic that didn't exist a decade ago when DSOs were a niche buyer category.

Regional and Market-Level Dynamics

Consolidation isn't distributed evenly across the country, and that unevenness is itself a strategic signal. HPI's state-level data shows Colorado and Oklahoma experiencing the sharpest increases in DSO affiliation in recent years — in both states, more than one in four dentists within 10 years of graduation is now DSO-affiliated, ahead of the national rate for that cohort. Minnesota has also emerged as a high-affiliation state. These patterns tend to track two underlying variables: regulatory environment (some states restrict the corporate practice of dentistry more tightly than others, which shapes how DSOs can legally structure ownership) and the density of existing PE-backed platforms, since acquirers generally pay a premium for practices that fit inside an existing regional cluster rather than opening a standalone outpost.

This clustering behavior also explains why "national market size" figures can be misleading at the practice level. A solo general dentist in a rural market with no nearby DSO presence faces a fundamentally different competitive and valuation environment than a comparable practice inside, say, the Dallas–Fort Worth or South Florida metro areas, where multiple platforms are actively bidding for density. Practice owners evaluating their options are generally better served by asking which platforms are acquiring in their specific metro or region than by benchmarking against national affiliation percentages.

What This Means for Practice Owners and Operators

None of this means independent practice is disappearing — 72.5% ownership, even on a declining trend, is still the large majority of the market. But it does mean the strategic calculus has changed. For practice owners weighing a sale, geographic density inside an existing DSO cluster, technology infrastructure, and patient retention above roughly 85% are now explicitly priced into valuation, not just described as "nice to have." For DSOs and PE sponsors, the platforms winning the most competitive processes are the ones that can show operational discipline — clean financials, defensible EBITDA add-backs, and integration playbooks — rather than simply outbidding on multiple.

For practices that intend to stay independent, the pressure is less about an existential threat and more about matching DSO-level infrastructure without DSO-level scale: centralized scheduling and recall systems, group purchasing where available, and a deliberate technology roadmap rather than reactive software purchases. The data suggests the practices most exposed to consolidation pressure aren't necessarily the smallest ones — they're the ones without a clear operational strategy, regardless of size.

There is also a middle path that the affiliation statistics don't fully capture: informal or "invisible" DSO structures, where a practice adopts shared services, group purchasing, or centralized back-office support without transferring equity or joining a formally branded platform. These structures let independent owners capture some of the cost and efficiency benefits associated with consolidation while retaining clinical and brand autonomy — a middle ground that is likely underrepresented in headline affiliation percentages precisely because it doesn't show up as a formal DSO relationship in ADA survey categories.

For PE sponsors active in the dental consolidation market, our DSO acquisition due diligence guide covers the operational checklist that financial diligence consistently misses.

For practice owners evaluating their options in the current consolidation environment, our dental practice valuation guide covers current EBITDA multiples, buyer type differences, and how to maximize valuation before going to market.

For DSOs and PE sponsors evaluating where to deploy capital, the multiple-per-EBITDA-tier data suggests that pure scale is no longer sufficient to win the most competitive processes. With more than 130 active PE-backed platforms and average sale processes generating five-plus competing offers on well-run practices, according to FOCUS Investment Banking's 2026 guidance for sellers, differentiation increasingly comes from integration track record and post-acquisition operational support rather than headline purchase price alone. Sponsors that can demonstrate retained-provider satisfaction and de novo growth within acquired locations — not just acquisition velocity — are the ones positioned to keep winning competitive bids as the buyer pool grows more crowded.

Frequently Asked Questions

What percentage of U.S. dentists are affiliated with a DSO in 2026?
The most recent verified figure, from the ADA Health Policy Institute, shows 16.1% of U.S. dentists affiliated with a DSO as of 2024 (the latest year with published census-style data), up from 7.4% in 2015. Some market-research projections cite higher figures for 2026, but these use broader or different definitions of "affiliation" than the ADA's survey methodology.

What multiple do dental practices sell for in 2026?
Adjusted EBITDA multiples generally range from 5x–7x for solo and small-group practices to 10x–14x (occasionally higher) for platform-scale groups with $10M or more in EBITDA. Specialty practices, particularly oral surgery, typically trade at a premium over general dentistry.

Is private equity the main buyer of dental practices?
Private equity backs the majority of active DSO consolidators — roughly 130 PE-backed platforms are currently acquiring in the U.S. — but not all large DSOs are PE-owned. Pacific Dental Services is founder-owned, Mortenson Dental Partners is structured as an ESOP, and several dentist-owned alternatives compete directly against PE-backed platforms for acquisitions.

Is dental consolidation slowing down?
No. Deal volume and DSO affiliation rates have both continued to climb through 2026, and rate cuts since late 2024 have supported a recovery in platform-level valuations after the 2022–2023 compression tied to higher borrowing costs.

Sources

1. American Dental Association, Health Policy Institute — U.S. Dentist Workforce, 2025 Update
2. American Dental Association, Health Policy Institute — Practice Ownership Trends in Dentistry: A New Look at Old Data
3. American Dental Association, Health Policy Institute — Practice Modalities Among U.S. Dentists
4. Nasseh, K. et al. — peer-reviewed research on private-equity-affiliated dental practice growth, 2015–2021
5. DealSeam — DSO & PE Roll-Up Tracker 2026
6. Medix Dental — 15 Largest Dental Service Organizations (DSOs) in the US for 2026
7. CT Acquisitions — Dental and DSO M&A Multiples Report 2026
8. CT Acquisitions — Dental DSO PE Roll-Up Tracker: 2026 Platforms
9. FOCUS Investment Banking — Dental Private Equity: A Guide for Practice Owners
10. Precedence Research — U.S. Dental Support Organizations (DSO) Market Size
11. Federal Reserve — H.15 Selected Interest Rates and FOMC rate decision history